Possible involvement of GABAergic modulation in the protective effect of gabapentin against immobilization stress-induced behavior alterations and oxidative damage in mice

Fundamental and Clinical Pharmacology

Volumn 21, Issue 6, 2007, Pages 575-581

  Kumar, Anil ^a   Goyal, Richa ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Anxiety; Gabapentin; Immobilization stress; Lipid peroxidation; Locomotor activity; Muscimol; Picrotoxin

Indexed keywords

CATALASE; GABAPENTIN; GLUTATHIONE; MALONALDEHYDE; MUSCIMOL; NITRITE; PICROTOXIN; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ANXIETY; ARTICLE; BEHAVIOR; BRAIN; CHEMICAL ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; GABAERGIC SYSTEM; IMMOBILIZATION; IMMOBILIZATION STRESS; LATENT PERIOD; LOCOMOTION; MOBILIZATION; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AMINES; ANIMALS; BEHAVIOR, ANIMAL; CATALASE; CYCLOHEXANECARBOXYLIC ACIDS; GABA MODULATORS; GAMMA-AMINOBUTYRIC ACID; GLUTATHIONE; IMMOBILIZATION; MICE; MOTOR ACTIVITY; MUSCIMOL; OXIDATION-REDUCTION; PICROTOXIN; STRESS, PSYCHOLOGICAL;

EID: 36348980962     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2007.00524.x     Document Type: Article

References (48)

1. Das A., Rai D., Dikshit M., Patil G., Nath C. Nature of stress: differential effects on brain acetyl cholinesterase activity and memory in rats. Life Sci. (2005) 77 2299 2311.
2. Esch T., Fricchione G.L., Stefano G.B. The therapeutic use of the relaxation response in stress related diseases. Med. Sci. Monit. (2003) 9 RA 23 24.
3. Jacobson l., Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamo- pituitary- adrenocortical axis. Endocr. Rev. (1991) 12 118 134.
4. Liu J., Wang X., Shigenaga M.K., Yeo H.C., Mori A., Ames B.N. Immobilisation stress causes oxidative damage to lipid, protein and DNA in the brain of rats. FASEB J. (1996) 10 1532 1538.
5. Liu J., Wang X., Mori A. Immobilisation stress - induced antioxidant defense changes in rat plasma, effect of treatment with reduced glutathione. Int. J. Biochem. (1994) 26 511 517.
6. Reddy D.S., Kulkarni S.K. Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging and dizocilpine- induced learning impairment. Brain Res. (1998) 799 215 229.
7. Mombereau C., Kaupmann K., Froestl W., Sansig G., van der Putten H., Cryan J.F. Genetic and Pharmacological evidence of a role for GABAB receptors in the modulation of anxiety and antidepressant like behavior. Neuropsychopharmacology (2004) 29 1050 1062.
8. Dhir A., Padi S.V., Naidu P.S., Kulkarni S.K. Protective effect of Naproxen (non selective COX inhibitor) or rofecoxib (selective COX inhibitor) on immobilization stress induced behavioral and biochemical alterations in mice. Eur. J. Pharmacol. (2006) 27 192 198.
9. Frye M.D. A Placebo Controlled Study of Lamotrigine and Gabapentin monotherapy in Refractory mood disorders. J. Clin. Psychopharmacol. (2000) 20 607 614.
10. Rose M.A., Kam P.C.A. Gabapentin: pharmacology and its use in pain management. Anaesthesia (2002) 57 451 462.
11. Ahmadi M.P. Gabapentin and posttraumatic stress disorder. Ann. Pharmacother. (2003) 37 664 666.
12. Williams A.J., Bautista C.C., Chen R. W. et al. Evaluation of gabapentin and ethosuximide for treatment of acute nonconvulsive seizures following ischemic brain injury in rats. J. Pharmacol. Exp. Ther. (2006) 318 947 955.
13. Pavone A., Cardile V. An in vitro study of new antiepileptic drugs and astrocytes. Epilepsia (2003) 10 34 39.
14. Baydas G., Sonkaya E., Tuzcu m., Yasar A., Donder E. Novel role for gabapentin in neuroprotection of central nervous system in streptozotocine- induced diabetic rats. Acta. Pharmacol. Sin. (2005) 26 417 422.
15. Lagreze W.A., Muller-Velten R., Feuerstein T.J. The neuroprotective properties of gabapentin-lactam. Graefes Arch. Clin. Exp. Ophthalmol. (2001) 239 845 849.
16. Li X., Ketter T.A., Frye M.A. Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders? J. Affect. Disord. (2002) 69 1 14.
17. Sur T.K., Bhattacharya D. The effect of Panax Ginseng and diazepam on brain and hypothalamic 5- hydroxytryptamine during stress. Indian J. Pharmacol. (1997) 29 318 321.
18. Kulkarni S.K., Reddy D.S. Animal behavioral models for testing antianxiety agents. Method. Find. Exp. Clin. Pharmacol. (1996) 18 219 230.
19. Wills E.D. Mechanism of lipid peroxide formation in animal tissues. Biochem. J. (1966) 99 667 676.
20. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. (1959) 82 470 486.
21. Green L.C., Wagner D.A., Glagowski J. Analysis of nitrate, nitrite and [15 N] nitrate in biological fluids. Anal. Biochem. (1982) 126 131 138.
22. Luck H. Catalase, in : Bergmeyer H.U. (Ed), Methods of Enzymatic Analysis, Academic Press, New York, 1971, pp. 885 893.
23. Lowry O.H., Rosenberg N.J., Farr A.L., Randall R.J. Protein measurement with the Folin-phenol reagent. J. Biol. Chem. (1951) 193 265 275.
24. Imbe H., Iwai-Liao Y., Senba E. Stress induced hyperalgesia: animal model and putative mechanisms. Front. Biosci. (2006) 11 2179 2192.
25. McEWEN B.S. Protection and damage from acute and chronic stress. Ann. NY Acad. Sci. (2004) 1032 1 7.
26. Metz G.A., Jadavji N.M., Smith L.K. Modulation of motor function by stress: a novel concept of the effects of stress and corticosterone on behavior. Eur. J. Neurosci. (2005) 22 1190 1200.
27. Sevgi S., Ozek M., Eroglu L. L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress. Methods Find. Exp. Clin. Pharmacol. (2006) 28 95 99.
28. Torres I.L., Vasconcellos A.P., Silveira Cucco S.N., Dalmaz C. Effect of repeated stress on novelty-induced antinociception in rats. Braz. J. Med. Biol. Res. (2001) 34 241 244.
29. Yoneda Y., Kanmori K., Ida S., Kuriyama K. Stress induced alterations in metabolism of gamma- aminobutyric acid in rat brain. J. Neurochem. (1983) 40 350 360.
30. Shugalev N.P., Stavrovskaia A.V., Iamshchikova N.G. Effect of neurotensin on the behavior of rats with damaged serotoninergic neurons under immobilization stress]. Zh. Vyssh. Nerv. Deiat. Im. IP. Pavlova. (2005) 55 671 676.
31. Ruiz M.R., Quinones A.G., Diaz N.L., Tapia F.J. Acute immobilization stress induces clinical and neuroimmunological alterations in experimental murine cutaneous leishmaniasis. Br. J. Dermatol. (2003) 149 731 738.
32. Kvetnansky R., Sun C.L., Torda T., Kopin I.J. Plasma epinephrine and norepinephrine levels in stressed rats. Effect of adrenolectomy. Pharmacologist (1977) 19 241 251.
33. Herve D., Tassin J.P., Barthelemy C., Blanc G., Lavielle S., Glowinski J. Difference in the sensitivity of mesocortical dopaminergic neurons to stress in the BALB/C mice and C57 BL/6 mice. Life Sci. (1979) 25 1659 1664.
34. Gal E.M., Hwater R.D., Milland S.A. Studies on the metabolism of 5 hydroxy tryptamine (serotonin) IV. Hydroxylation and amines in cold stressed reserpinised rat. Proc. Soc. Exp. Biol. Med. (1968) 128 412 415.
35. Chouniard G., Beauclair L., Belanger M.C. Gabapentin: long-term antianxiety and hypnotic effects in psychiatric patients with comorbid anxiety-related disorders. Can. J. Psychiatry (1998) 43 305.
36. Bremmer J.D., Innis R.B., Southwick S.M., Staib L., Zoghbi S., Charney D.S. Decreased benzodiazepine receptor binding in prefrontal cortex in combat- related posttraumatic stress disorder. Am. J. Psychiatry (2000) 157 1120 1126.
37. Medina J., Novas M.L., De Robertis E. Changes in benodiaipine receptors by acute stress: different effect of chronic diazepam or RO 15-1788 treatment. Eur. J. Pharmacol. (1983) 96 181 185.
38. Miller L.G., Thompson M.L., Greenblatt D.J., Deutsch S.I., Shader R.I., Paul S.M. Rapid increase in brain benzodiazepine receptor binding following defeat stress in mice. Brain Res. (1987) 414 395 400.
39. Molodavkin G.M., Voronina T.A., Aldarmaa Z.H., Meletova O.K. Stress- induced alteration of the antiaggressive effect of anxiolytics. Eksp. Klin. Farmacol. (2004) 67 3 6.
40. Dombrowski P.A., Fernandes L.H., Andreatini R. Picrotoxin blocks the anxiolytic- and panicolytic-like effects of sodium valproate in the rat elevated T-maze. Eur. J. Pharmacol. (2006) 10 72 76.
41. Dalvi A., Rodgers R.J. Anxiolytic effects of valproate and diazepam in mice are differentially sensitive to picrotoxin antagonism. Pharmacol. Biochem. Behav. (2001) 68 23 32.
42. Reddy D.S., Kulkarni S.K. Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice. Brain Res. (1997) 752 61 71.
43. Ashton H., Allan H. GABA-Ergic Drugs: Exit Stage Left, Enter Stage Right. J. Psychopharmacol. (2003) 17 174 178.
44. Natelson B.H. Stress, predisposition and the onset of serious disease: implications about psychosomatic etiology. Neurosci. Biobehav. Rev. (1983) 7 511 527.
45. Sherki Y.G., Melemed E., Offen D. Oxidative stress induced- neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology (2001) 40 959 975.
46. Nazar M., Jessa M., Plaznik A. Benzodiazipine-GABA-A receptor complex ligands in two models of anxiety. J. Neural. Transm. (1997) 104 733 746.
47. O'Connor T.M., O'Halloran D.J., Shanahan F. The stress response and the hypothalamo- pituitary- adrenocortical axis: from molecule to melancholia. Q. J. Med. (2000) 93 323 333.
48. Stepien K., Tomaszewski M., Czuczwar S.J. Profile of anticonvulsant activity and neuroprotective effects of novel and potential antiepileptic drugs-an update. Pharmacol. Rep. (2005) 57 719 733.